References
Lee KC (2015) Changes of muscarinic receptors and connexin-43 expression as a mechanism of overactive bladder in ovariectomized rats. World J Urol 33:1875–1879
Loewenstein WR (1979) Junctional intercellular communication and the control of growth. Biochim Biophys Acta 560:1–65
Retamal MA, Reyes EP, Garcia IE, Pinto B, Martinez AD, Gonzalez C (2015) Diseases associated with leaky hemichannels. Front Cell Neurosci 9:267
John H, Wang X, Wehrli E, Hauri D, Maake C (2003) Evidence of gap junctions in the stable nonobstructed human bladder. J Urol 169:745–749
Sui GP, Rothery S, Dupont E, Fry CH, Severs NJ (2002) Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 90:118–129
Corteggio A, Florio J, Roperto F, Borzacchiello G (2011) Expression of gap junction protein connexin 43 in bovine urinary bladder tumours. J Comp Pathol 144:86–90
Gee J, Tanaka M, Grossman HB (2003) Connexin 26 is abnormally expressed in bladder cancer. J Urol 169:1135–1137
Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML (2005) Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719:125–145
Kandouz M, Batist G (2010) Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets 14:681–692
Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M (2009) Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 11:323–338
Asamoto M, Takahashi S, Imaida K, Shirai T, Fukushima S (1994) Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis. Carcinogenesis 15:2163–2166
Acknowledgments
Prof. Carola Meier (Saarland University) has generously provided all the antibodies used in this study. The authors are grateful to Ingrid Lang for excellent technical assistance and to Ann Soether for her editing help.
Authors’ contribution
D. Comberg contributed to data collection, data analysis and co-writing of the manuscript. A. Gauer analyzed the data. T. Tschernig developed the project and wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict regarding the publication of this paper.
Ethical standards
The study was approved by the Ethical Committee of the Saarland and by the Ethical Committee of Rheinland-Pfalz. Informed consent was collected from the participants of the study.
Rights and permissions
About this article
Cite this article
Comberg, D., Gauer, A. & Tschernig, T. First findings of gap junction proteins in human urothelial carcinoma. World J Urol 34, 145–147 (2016). https://doi.org/10.1007/s00345-015-1717-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1717-y